Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Michaela Liedtke, Stanford University
ClinicalTrials.gov Identifier:
NCT01114282
First received: April 29, 2010
Last updated: August 4, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2015
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)